Alex Gorsky earned a whopping $29.6M in 2020 as drugmaker pivoted around Covid-19 vaccine R&D

In nearly nine years helming J&J, CEO Alex Gorsky has watched his drugmaker morph into the single largest company in biopharma. But 2020 was a year like no other, requiring J&J’s massive machinery to pivot around developing a Covid-19 vaccine. For Gorsky, that effort proved particularly lucrative.